HUTCHMED begins Phase I/IIa trial of HMPL-A580 for solid tumours

​HUTCHMED has commenced a Phase I/IIa clinical trial of its second ATTC, HMPL-A580, targeting patients with unresectable, advanced or metastatic solid tumours in the US and China.

The post HUTCHMED begins Phase I/IIa trial of HMPL-A580 for solid tumours appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

Philips launches Rembra CT system for acute imaging
Affinia receives FDA fast track designation for AFTX-201
Droplet improves genomic analysis speed using NVIDIA Parabricks software
Kyowa Kirin discontinues ongoing trials of rocatinlimab
Esperion to acquire Corstasis for cardiovascular franchise expansion

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us